Public Health Vaccines LLC
Public Health Vaccines LLC is a privately held biotechnology company developing vaccines for the prevention and control of emerging infectious diseases. This team has an in depth understanding of the rVSV technology platform, demonstrated expertise advancing other filovirus vaccines, and in general, a proven track record of successfully developing new vaccine candidates to late stage development and registration.
Crozet BioPharma works to accelerate the development of biological products to prevent or treat important diseases. Its founding principle is to have a lasting, positive impact on people’s health and lives.
Funding From the Coalition for Epidemic Preparedness Innovations
Creation of CEPI
The Coalition for Epidemic Preparedness Innovations (CEPI) was launched at Davos 2017 as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics.
CEPI Gets Funded
CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations working to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for affected populations during outbreaks.
CEPI Funds Public Health Vaccines to develop Nipah vaccine
CEPI has prioritized funding vaccines that can help prevent disease outbreaks from becoming humanitarian crises. CEPI supports the development of vaccines and platform technologies against deadly diseases for which no licensed vaccines are currently available. In January 2019, CEPI funded Public Health Vaccines to develop a vaccine against the Nipah virus.